why choose us

First received: January 04, 2024

Clinical Trial: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through Menopause

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hot Flashes

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Fezolinetant in Japanese Women Experiencing Vasomotor Symptoms (Hot Flashes) Associated With Menopaus

Brief Summary: Hot flashes are the most common reason women going through menopause seek medical attention.Hormone replacement therapy, or HRT, is most often prescribed to treat hot flashes.However, HRT can't be used by all women or for as long as may be needed.Researchers want to find other ways to treat hot flashes.Fezolinetant is a medicine to treat hot flashes in women going through menopause.Fezolinetant is an approved medicine in the US.Further studies are needed before it is available in other regions such as…

Read more